Literature DB >> 12296295

A role for the peroxisome proliferator-activated receptor alpha in T-cell physiology and ageing immunobiology.

Dallas C Jones1, Bernadette M Manning, Raymond A Daynes.   

Abstract

Peroxisome proliferator-activated receptor (PPAR) represents an important member of the nuclear hormone receptor superfamily that can be activated by a variety of natural fatty acids, some of their metabolites and by commonly-used anti-lipidaemic drugs. We recently demonstrated PPAR expression in T lymphocytes, where it controls the initiation of transcription of T-box expressed in T-cells (T-bet) independent of added agonist. T-bet is an activation-inducible transcription factor regulator of interleukin 2 (suppression) and interferon (stimulation) synthesis. A suppressed ability to produce interleukin 2 and an enhanced production of interferon occurs in activated T-cells from PPAR-/- mice, as well as in T-cells from wild-type aged animals whose lymphocytes express lowered basal levels of PPAR. The dysregulated expression and/or function of cytokines, glucocorticoids or leptin that occurs with advanced age could all be responsible for the reduced expression of PPAR. Dietary supplementation of aged mice with vitamin E, or supplementation with known agonists of PPAR, was associated with elevation of lymphocyte expression of this nuclear hormone receptor, restoration of control over T-bet expression and elimination of the dysregulated production of interleukin 2 and interferon following lymphocyte activation. Interleukin 2 and interferon play very important roles in the initiation and/or regulation of immune, inflammatory and autoimmune disease states. Thus, the mechanisms that control the timing, magnitude and duration of specific cytokine production by activated T lymphocytes need clarification before appropriate nutritional or therapeutic strategies can be devised to treat disease conditions where cytokine expression and/or activities are deemed to be dysregulated and responsible.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12296295     DOI: 10.1079/pns2002173

Source DB:  PubMed          Journal:  Proc Nutr Soc        ISSN: 0029-6651            Impact factor:   6.297


  5 in total

1.  Transcriptional modulation of the immune response by peroxisome proliferator-activated receptor-{alpha} agonists in autoimmune disease.

Authors:  Anne R Gocke; Rehana Z Hussain; Yuhong Yang; Haiyan Peng; Jeffrey Weiner; Li-Hong Ben; Paul D Drew; Olaf Stuve; Amy E Lovett-Racke; Michael K Racke
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

Review 2.  Role of transcription factors in mediating post-ischemic cerebral inflammation and brain damage.

Authors:  Jae-Hyuk Yi; Seung-Won Park; Ramya Kapadia; Raghu Vemuganti
Journal:  Neurochem Int       Date:  2007-05-03       Impact factor: 3.921

3.  Regulation of Immune Responses and Autoimmune Encephalomyelitis by PPARs.

Authors:  Yuhong Yang; Amy E Lovett-Racke; Michael K Racke
Journal:  PPAR Res       Date:  2010-12-22       Impact factor: 4.964

4.  Pro-Survival Lipid Sphingosine-1-Phosphate Metabolically Programs T Cells to Limit Anti-tumor Activity.

Authors:  Paramita Chakraborty; Silvia G Vaena; Krishnamurthy Thyagarajan; Shilpak Chatterjee; Amir Al-Khami; Shanmugam Panneer Selvam; Hung Nguyen; Inhong Kang; Megan W Wyatt; Uday Baliga; Zachariah Hedley; Rose N Ngang; Beichu Guo; Gyda C Beeson; Shahid Husain; Chrystal M Paulos; Craig C Beeson; Michael J Zilliox; Elizabeth G Hill; Meenal Mehrotra; Xue-Zhong Yu; Besim Ogretmen; Shikhar Mehrotra
Journal:  Cell Rep       Date:  2019-08-13       Impact factor: 9.423

5.  Peroxisome proliferator-activated receptors alpha and gamma down-regulate allergic inflammation and eosinophil activation.

Authors:  Gaetane Woerly; Kohei Honda; Marc Loyens; Jean-Paul Papin; Johan Auwerx; Bart Staels; Monique Capron; David Dombrowicz
Journal:  J Exp Med       Date:  2003-08-04       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.